TGA Approval

NUWIQ simoctocog alfa recombinant human factor VIII (Human-cl rhFVIII) 250 IU powder for injection vial and solvent for injection pre-filled syringe (213941)

ARTG ID

213941

ARTG Name

NUWIQ simoctocog alfa recombinant human factor VIII (Human-cl rhFVIII) 250 IU powder for injection vial and solvent for injection pre-filled syringe

Sponsor

Octapharma Australia Pty Ltd

ARTG Date

November 10, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Octapharma Australia Pty Ltd

Sponsor Item Name

octapharma australia pty ltd

Active Ingredients

Ingredient Name

simoctocog alfa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

NUWIQ simoctocog alfa recombinant human factor VIII (Human-cl rhFVIII) 250 IU powder for injection vial and solvent for injection pre-filled syringe (213941) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

NUWIQ simoctocog alfa recombinant human factor VIII (Human-cl rhFVIII) 250 IU powder for injection vial and solvent for injection pre-filled syringe (213941)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal